Kidney Transplant Rejection
95
14
24
23
Key Insights
Highlights
Success Rate
68% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.6%
11 terminated out of 95 trials
67.6%
-18.9% vs benchmark
11%
10 trials in Phase 3/4
26%
6 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (95)
Observational Cohort Study Renal Transplantation University Hospitals Leuven
Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)
Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized
Trifecta-Kidney cfDNA-MMDx Study
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
Using MSCs for Chronic Active Antibody Mediated Rejection
AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Platelet Aggregation in the Diagnosis of Acute Graft Rejection
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation